The US government has announced its support for a new British vaccine, which promises to provide an effective defence against the most deadly naturally occurring substance, botulism.
The technology is being developed by Cambridge Biostability. The vaccine will render botulism no greater a risk to public health than tetanus and eliminating its danger as a potential weapon.
Bruce Roser, Chief Scientific Advisor for Cambridge Biostability explains: “With our stable liquid technology you can encapsulate each toxoid in its own microsphere. The microspheres can be mixed and kept at room temperature without harming the vaccine. This means that for the first time it is possible to create a single multivalent vaccine which can be stored safely without refrigeration.”
